• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things? Product Image

Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?

  • Published: June 2011
  • Region: World
  • 59 Pages
  • Eularis

FEATURED COMPANIES

  • ASTD
  • B-to-B Online
  • CMO Council
  • CSO Insights
  • Eularis
  • Forrester
  • MORE

With the ever increasing pressure to ensure maximum return on investment, sales force effectiveness (SFE) is becoming a high priority area in the global pharmaceutical industry. Sales force represents the largest spend in sales and marketing and yet study after study shows that the returns gained from this spend is not particularly strong and one recent IMS report found that pharma sales force effectiveness declined by 23% in the recent period of 2004 to 2005. Better metrics must be used to measure both the effectiveness and financial impact of SFE for this very significant budget.

The startling discovery that this comprehensive report uncovers is that the very metrics currently being used to assess sales force effectiveness are in fact themselves aiding its decline. Traditional pharmaceutical organizations are rigorously tracking and managing sales activity, but still falling short. Data emerging from the research concludes that current metrics are more focused on efficiencies than effectiveness – and do so to their own detriment. This report dissects current SFE metrics and their limitation for the pharmaceutical industry in the United States, Europe and Japan.

The READ MORE >

Section 1: Background - The Scale of the Sales Force Effectiveness Problem

Section 2: Assessment - Current Metrics Used and their Contribution to the Problem
- Sales Force Size and Share Of Voice
- Sales Calls per Day
- What's Missing
- Future Measures

Section 3: The Problem with Sales Tools

Section 4: Changing the Focus
- Customer Focus
- Targeting
- United States
- Ii. Relationships
- Iii. Call Quality
- Message Focus
- Continuous Monitoring

Section 5: Problems Specific to Europe with Sales Force Effectiveness
- Western Europe
- Central and Eastern Europe

Section 6: The Japanese Market: Sales Force Effectiveness Issues

Section 7: The Right Metrics to Solve the Problems
- Efficiency versus Effectiveness
- Targeting
- Effectiveness Measurement: Moving Beyond 'recall' And 'intent To Prescribe'
- Sales Forces Optimisation

Section 8: Implementation Issues
- Productivity
- Action Plan
- Emotional Buy In
- Where Does 'e' Fit In: The Role of e-detailing
- CRM and other Technologies

Section 9: Results Analysis

Case Studies

Section 10: Ongoing Monitoring

Section 11: The Future?

- Eularis
- Novartis
- IBM
- Caliper Research Organization
- American Marketing Association
- B-to-B Online
- CMO Council
- ASTD
- CSO Insights
- IMS
- Forrester
- Gartner Group

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos